Moderna
MRNA
$129.06
Share price
0.58%
Change (1 day)
-0.92%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Moderna (MRNA) Fails to deliver data
Key failure to deliver metrics for Moderna :
- Last SEC data release: 2024-04-30
- Last 15 days FTD volume: $1.1 M
- Last 3 months FTD volume: $38.52 M
- Last year FTD volume: $0.13 B
Failures to deliver for Moderna (MRNA) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Moderna (MRNA) - since 2018
Volume in USD (price x number of shares), data since 2018Moderna (MRNA) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $57.38 M | -57.75% |
| 2023 | $0.13 B | -50.15% |
| 2022 | $0.27 B | -85.7% |
| 2021 | $1.90 B | 158.2% |
| 2020 | $0.73 B | 369.18% |
| 2019 | $0.15 B | 1011.49% |
| 2018 | $14.15 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.13 B | $0.59 B | 🇺🇸 USA |
 Novartis NVS | $18.64 M | $83.53 M | 🇨🇭 Switzerland |
 Merck MRK | $6.57 M | $0.15 B | 🇺🇸 USA |
 Regulus Therapeutics RGLS | $3.96 M | $4.04 M | 🇺🇸 USA |
 Athersys ATHX | $0.09 M | $0.71 M | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $3.35 M | $37.96 M | 🇺🇸 USA |
 Arrowhead Pharmaceuticals
ARWR | $3.95 M | $9.77 M | 🇺🇸 USA |